Patent · US Active

Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor

US11254686B1 · kind B1 · utility

0Cited by
8References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2018
Grant dateFeb 22, 2022
Priority date—
Expiry dateAug 31, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed herein, inter alia, are certain substituted thieno[3,2-b]pyrimidine compositions and methods for modulating Adenosine Receptors, for example, having the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.